Imperial College London

Dr David Wilkie

Faculty of MedicineDepartment of Brain Sciences

Honorary Research Officer



+44 (0)20 3313 0675d.wilkie




10L18Lab BlockCharing Cross Campus





David Wilkie has been employed by Imperial College since 2007 and is responsible for managing a number of academic and commercial trials as part of the MS research team based at Charing Cross Hospital.  

In 2020, he completed a PhD under the Faculty of Medicine at Imperial College under the primary supervision of Professor Richard Nicholas.

Prior to this, he occupied various positions at the Newcastle upon Tyne NHS Trust as well as roles in journalism and media production in the North East of England.  Most recently this has led to him producing three films and published articles in the specialty of MS.



Wilkie D, Solari A, Nicholas R, 2020, The impact of the face-to-face consultation on decisional conflict in complex decision-making in multiple sclerosis: a pilot study, Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol:6, ISSN:2055-2173, Pages:1-11

Wilkie D, Solari A, Nicholas R, 2019, Initiating disease modifying treatments in multiple sclerosis: measuring the decision process using decisional conflict and decisional regret scales, Multiple Sclerosis Journal - Experimental, Translational and Clinical, ISSN:2055-2173

Chataway J, Schuerer N, Alsanousi A, et al., 2014, Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial, Lancet, Vol:383, ISSN:0140-6736, Pages:2213-2221

More Publications